- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07353021
Langtidseffekter af et biofelt-patch på angst, søvn og energi
Klinisk forsøg om langtidseffekterne af et biofelt-patch på angst, søvn og energi. Et randomiseret dobbeltblindt placebo-kontrolleret 4-ugers forsøg.
The goal for this clinical trial is to compare an active biofield non-transdermal skin patch to a placebo patch in people who frequently experience anxiety.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
The goal for this clinical trial is to document effects of a photobiomodulating non-transdermal patch compared to a placebo patch, in a randomized double-blind placebo-controlled design.
Data on stress and anxiety levels will be collected using the GAD and OASIS questionnaires as well as the Warwick-Edinburgh Mental Wellbeing Scales collected. The data collected will show whether the daily use of the patch leads to a change in general self-reported stress and anxiety levels. Data on energy levels will be collected using a Wellness questionnaire. Data on sleep quality will be collected using the Leeds sleep evaluation questionnaire, to document whether using the active patch impacts self-reported sleep.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Alex Cruickshank
- E-mail: Alex@nislabs.com
Undersøgelse Kontakt Backup
- Navn: Gitte S Jensen, PhD
- Telefonnummer: 541 882 0112
- E-mail: Gitte@nislabs.com
Studiesteder
-
-
Oregon
-
Klamath Falls, Oregon, Forenede Stater, 97601
- Rekruttering
- NIS Labs
-
Kontakt:
- Gitte S. Jensen, PhD
- Telefonnummer: 5418840112
- E-mail: gitte@nislabs.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Healthy adults of all genders;
-
Age 18-75 years (inclusive);
-
BMI between 18.0 and 34.9 (inclusive)
-
Experiencing intermittent episodes of anxiety on a regular basis, leading to either avoiding specific situations, or experiencing stress both in anticipation of, and during such situations.
-
Specific situations that occur regularly that cause anxiety, for example:
- Performing specific tasks at work or at home;
- Inter-personal conflicts at work or at home;
- Driving or commuting;
- Fearful and worrying about one's own situation (such as paying bills);
- Worrying about ongoing problems experienced by others.
-
Exclusion Criteria:
- Cancer during past 12 months;
- Chemotherapy during past 12 months;
- Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication;
- Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
- Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change;
- Serious active illness within past 6 months;
- People who are pregnant, nursing, or trying to become pregnant.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Group 1
Participants will use an active biofield patch daily for 4 weeks. The active biofield patch will look identical to a placebo patch, and will be blinded. |
Non-transdermal patch |
|
Eksperimentel: Group 2
Participants will use a placebo patch daily for 4 weeks. The placebo patch will look identical to an active patch, and will be blinded. |
Non-transdermal patch |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
General Anxiety Disorder 7 (GAD 7) Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in anxiety score using the General Anxiety Disorder 7-item. The General Anxiety Disorder-7 scale evaluates anxiety severity using scores ranging from 0-21, where higher scores indicate higher anxiety severity. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Overal Anxiety Severity and Impairment Scale (OASIS) Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in Overall Anxiety Severity and Impairment Scale (OASIS) score. The Overall Anxiety Severity and Impairment scale evaluates anxiety and impact on daily living in participants with a score between 0 and 25, where higher scores indicate higher anxiety severity and impact on daily living. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Warwick-Edinburgh Mental Wellbeing Scale
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Changes from baseline in mental wellbeing using the Warwick-Edinburgh Mental Wellbeing scale. The Warwick-Edinburgh Mental Wellbeing scale evaluates self reported happiness and satisfaction as well as psychological functioning, good relationships with others, and self realization. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
|
Wellness Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
Change from baseline in wellness evaluated using a Wellness questionnaire. The Wellness questionnaire consists of 30 questions, generating scores for physical, mental functioning, emotional wellbeing, stress, social functioning, sleep, and energy/vitality, where higher scores reflect better wellness. |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks
|
|
Leeds Sleep Questionnaire
Tidsramme: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks.
|
Changes from baseline in sleep quality. The Leeds Sleep Evaluation Questionnaire is a 10 item linear-log scale based on questions across several domains of sleep, where higher scores reflect better sleep quality |
Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks.
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 206-008
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .